Prognostic markers such as the status of immunoglobulin VH gene (IgVH) mutations, chromosomal abnormalities, CD38 expression, and ZAP-70 expression have been useful in predicting the clinical outcome in CLL [3]–[5]. This evidence concerns the gene CD38 and B-cell chronic lymphocytic leukemia.